Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
<p>Abstract</p> <p>Background</p> <p>Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. A...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | BMC Psychiatry |
Online Access: | http://www.biomedcentral.com/1471-244X/11/12 |
_version_ | 1818580649529835520 |
---|---|
author | van Marwijk Harm Schoevers Robert van Valen Evelien Smit Filip Kamp Lillian Kok Gemma D Bockting Claudi LH Cuijpers Pim Riper Heleen Dekker Jack Beck Aaron T |
author_facet | van Marwijk Harm Schoevers Robert van Valen Evelien Smit Filip Kamp Lillian Kok Gemma D Bockting Claudi LH Cuijpers Pim Riper Heleen Dekker Jack Beck Aaron T |
author_sort | van Marwijk Harm |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. Accordingly, efforts to reduce the disabling effects of this chronic condition should shift to preventing recurrence, especially in patients at high risk of recurrence. Given its high prevalence and the fact that interventions are necessary during the remitted phase, new approaches are needed to prevent relapse in depression.</p> <p>Methods/design</p> <p>The best established effective and available psychological intervention is cognitive therapy. However, it is costly and not available for most patients. Therefore, we will compare the effectiveness and cost-effectiveness of self-management supported by online CT accompanied by SMS based tele-monitoring of depressive symptomatology, i.e. Mobile Cognitive Therapy (M-CT) versus treatment as us usual (TAU). Remitted patients (n = 268) with at least two previous depressive episodes will be recruited and randomized over (1) M-CT in addition to TAU versus (2) TAU alone, with follow-ups at 3, 12, and 24 months. Randomization will be stratified for number of previous episodes and type of treatment as usual. Primary outcome is time until relapse/recurrence over 24 months using DSM-IV-TR criteria as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). For the economic evaluation the balance between costs and health outcomes will be compared across strategies using a societal perspective.</p> <p>Discussion</p> <p>Internet-based interventions might be helpful in empowering patients to become their own disease managers in this lifelong recurrent disorder. This is, as far as we are aware of, the first study that examines the (cost) effectiveness of an E-mental health program using SMS monitoring of symptoms with therapist support to prevent relapse in remitted recurrently depressed patients.</p> <p>Trial registration</p> <p>Netherlands Trial Register (NTR): <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2503">NTR2503</a></p> |
first_indexed | 2024-12-16T07:20:57Z |
format | Article |
id | doaj.art-c8506e8e623a48119f83b50d5c9f429f |
institution | Directory Open Access Journal |
issn | 1471-244X |
language | English |
last_indexed | 2024-12-16T07:20:57Z |
publishDate | 2011-01-01 |
publisher | BMC |
record_format | Article |
series | BMC Psychiatry |
spelling | doaj.art-c8506e8e623a48119f83b50d5c9f429f2022-12-21T22:39:39ZengBMCBMC Psychiatry1471-244X2011-01-011111210.1186/1471-244X-11-12Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocolvan Marwijk HarmSchoevers Robertvan Valen EvelienSmit FilipKamp LillianKok Gemma DBockting Claudi LHCuijpers PimRiper HeleenDekker JackBeck Aaron T<p>Abstract</p> <p>Background</p> <p>Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. Accordingly, efforts to reduce the disabling effects of this chronic condition should shift to preventing recurrence, especially in patients at high risk of recurrence. Given its high prevalence and the fact that interventions are necessary during the remitted phase, new approaches are needed to prevent relapse in depression.</p> <p>Methods/design</p> <p>The best established effective and available psychological intervention is cognitive therapy. However, it is costly and not available for most patients. Therefore, we will compare the effectiveness and cost-effectiveness of self-management supported by online CT accompanied by SMS based tele-monitoring of depressive symptomatology, i.e. Mobile Cognitive Therapy (M-CT) versus treatment as us usual (TAU). Remitted patients (n = 268) with at least two previous depressive episodes will be recruited and randomized over (1) M-CT in addition to TAU versus (2) TAU alone, with follow-ups at 3, 12, and 24 months. Randomization will be stratified for number of previous episodes and type of treatment as usual. Primary outcome is time until relapse/recurrence over 24 months using DSM-IV-TR criteria as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). For the economic evaluation the balance between costs and health outcomes will be compared across strategies using a societal perspective.</p> <p>Discussion</p> <p>Internet-based interventions might be helpful in empowering patients to become their own disease managers in this lifelong recurrent disorder. This is, as far as we are aware of, the first study that examines the (cost) effectiveness of an E-mental health program using SMS monitoring of symptoms with therapist support to prevent relapse in remitted recurrently depressed patients.</p> <p>Trial registration</p> <p>Netherlands Trial Register (NTR): <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2503">NTR2503</a></p>http://www.biomedcentral.com/1471-244X/11/12 |
spellingShingle | van Marwijk Harm Schoevers Robert van Valen Evelien Smit Filip Kamp Lillian Kok Gemma D Bockting Claudi LH Cuijpers Pim Riper Heleen Dekker Jack Beck Aaron T Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol BMC Psychiatry |
title | Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol |
title_full | Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol |
title_fullStr | Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol |
title_full_unstemmed | Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol |
title_short | Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol |
title_sort | disrupting the rhythm of depression using mobile cognitive therapy for recurrent depression randomized controlled trial design and protocol |
url | http://www.biomedcentral.com/1471-244X/11/12 |
work_keys_str_mv | AT vanmarwijkharm disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT schoeversrobert disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT vanvalenevelien disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT smitfilip disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT kamplillian disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT kokgemmad disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT bocktingclaudilh disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT cuijperspim disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT riperheleen disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT dekkerjack disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol AT beckaaront disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol |